Nuo

Nuo’s mix in June 2026 split nearly evenly between Tincture & Sublingual at 50.49% share and Topical at 49.51% share, but the trajectories diverged: Tincture & Sublingual was up 1.44% year over year while down 8.86% month over month, whereas Topical rose 19.31% year over year and 7.80% month over month. Average prices moved in opposite directions across the portfolio, with brand-level pricing down 4.06% year over year alongside a category gap where Tincture & Sublingual averaged $22.43 and Topical averaged $42.21. The pattern implies mix is tilting toward higher-priced Topicals on a growth path while Tincture & Sublingual provides volume stability but is soft intra-month, creating a near-term margin uplift opportunity if the Topical momentum persists.

With Tincture & Sublingual holding a rank of 4 in Colorado and a 1.44% year-over-year gain but an 8.86% month-over-month dip, Nuo’s core placement supports visibility even as short-term velocity cools; conversely, Topical’s 19.31% year-over-year and 7.80% month-over-month growth suggests share capture potential that can offset seasonal softness in drops. The brand’s 9.56% year-over-year sales increase alongside a 4.06% price decrease indicates volume-led expansion, and the near 1:1 split between 50.49% and 49.51% shares gives headroom to lean into Topical without overexposing to one format. The implication is a barbell positioning: protect fourth-place credibility in Tincture & Sublingual while reallocating promotional weight to sustain Topical’s higher ticket growth to stabilize margins and smooth month-to-month volatility.